PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
06-Jun-2022 Orthopaedic Prosthetics Market will witness a CAGR of over 4.5% through 2030 MARKITWIRED
06-Jun-2022 Over-the-Counter Pain Medication Market Research Report: Overview With Geographical Segmentation By Revenue With Forecast 2028 MARKITWIRED
05-Jun-2022 Updated Data for Janssen’s Bispecific Teclistamab Suggest Continued Deep and Durable Responses in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma Businesswire
05-Jun-2022 NANOBIOTIX: New Data Featuring NBTXR3 Plus Chemoradiation and in the Preoperative Setting Support Broad Applicability for Head and Neck Cancer and Other Solid Tumor Indications Businesswire
05-Jun-2022 NOXXON Presents Full Top-line Results From NOX-A12 Phase 1/2 GLORIA Trial in Glioblastoma at the 2022 ASCO Annual Meeting Businesswire
05-Jun-2022 Foundation Medicine Announces Strategic Collaboration with Arvinas Businesswire
05-Jun-2022 Adjuvant Treatment With Merck’s KEYTRUDA® (pembrolizumab) Demonstrates Statistically Significant & Clinically Meaningful Improvement in Distant Metastasis-Free Survival in Patients With Resected Stage IIB or IIC Melanoma in Phase 3 KEYNOTE-716 Trial Businesswire
05-Jun-2022 Creatv Bio’s LifeTracDx® Liquid Biopsy Predicts Response to New Line of Therapy for Metastatic Breast Cancer within 30 Days Businesswire
04-Jun-2022 MEI Pharma and Kyowa Kirin Report New Clinical Data on Zandelisib at American Society of Clinical Oncology Annual Meeting 2022 Businesswire
04-Jun-2022 CG Oncology Presents New Clinical Data on Two Ongoing Programs at The American Society of Clinical Oncology (ASCO) 2022 Annual Meeting Businesswire
04-Jun-2022 Nucleai to Publish Pathology-based Data at ASCO 2022 for Phase 2 Research of the Most Common Type of Non-Hodgkin’s Lymphoma Businesswire
04-Jun-2022 Puma Biotechnology Presents Final Results from the Biliary Tract Cohort of the Phase 2 SUMMIT ‘Basket’ Trial of Neratinib at the ASCO 2022 Annual Meeting Businesswire
04-Jun-2022 Longer-Term Data from CARTITUDE Program Continue to Show Deep and Durable Responses with Ciltacabtagene Autoleucel Across Lines of Therapy in Patients with Multiple Myeloma Businesswire
04-Jun-2022 Atara Biotherapeutics Announces First Clinical Data from Ongoing Tab-cel® European Multicenter Expanded Access Program (EAP) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting and Update on Tab-cel EMA Regulatory Progress Businesswire
04-Jun-2022 ABBVIE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against AbbVie, Inc. and Encourages Investors to Contact the Firm Businesswire
04-Jun-2022 Cybin Announces Additional Adelia Milestone Achievements Businesswire
03-Jun-2022 Bristol Myers Squibb Withdraws Supplemental Biologics License Application (sBLA) for Reblozyl® (luspatercept-aamt) for Non-transfusion Dependent (NTD) Beta Thalassemia Businesswire
03-Jun-2022 United Therapeutics Corporation to Present at the Jefferies Healthcare Conference Businesswire
03-Jun-2022 Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Businesswire
03-Jun-2022 Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Businesswire